Trial intelligence / Profile preview

Macrophage Markers in Wilson's Disease

NCT02702765Completed

Sponsor
Aarhus University
Start
Feb 2016
Primary completion
Feb 2020
Countries
1
01

Overview

Open-label, single-arm trial, sponsored by Aarhus University. Primary endpoints: Soluble CD163 at 3 years and Soluble Mannose Receptor at 3 years. Started Feb 2016; status: completed.

Beyond the preview

Go deeper on NCT02702765.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02702765.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call